Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5–SN38 Antibody–drug Conjugate in Neuroendocrine Prostate Cancer - Concepedia

Concepedia

Publication | Open Access

Regulation of CEACAM5 and Therapeutic Efficacy of an Anti-CEACAM5–SN38 Antibody–drug Conjugate in Neuroendocrine Prostate Cancer

DOI Full Paper Access

82

Citations

53

References

2020

Year

Diana C. DeLucia, Thomas M. Cardillo, Lisa S. Ang, Mark P. Labrecque, Ailin Zhang, James E. Hopkins, Navonil De Sarkar, Ilsa M. Coleman, Rui M. Gil da Costa, Eva Corey,

Clinical Cancer Research

Abstract

Our findings provide insights into the scope and regulation of CEACAM5 expression in prostate cancer and strong support for clinical studies of labetuzumab govitecan for NEPC.

References

	Year	Citations

Page 1